Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 AUD | +12.82% |
|
+27.54% | +151.43% |
26/06 | Cleo Diagnostics Secures US FDA Feedback for Ovarian Cancer Test | MT |
23/06 | 7,500,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 23-JUN-2024. | CI |
End-of-day quotes
Sector Diagnostic & Testing Substances
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
33.72M | - | - | - | - | - | |
11.96B | ||||||
6.6B | ||||||
5.75B | ||||||
5.51B | - | - | ||||
3.48B |
- Stock Market
- Equities
- COV Stock
- Charts Cleo Diagnostics Ltd
- Sector Chart